Suzuken Co., Ltd. (TYO:9987)
5,103.00
+32.00 (0.63%)
Aug 26, 2026, 9:49 AM JST
Suzuken Revenue
Suzuken had revenue of 628.96B JPY in the quarter ending June 30, 2026, with 6.09% growth. This brings the company's revenue in the last twelve months to 2.52T, up 4.65% year-over-year. In the fiscal year ending March 31, 2026, Suzuken had annual revenue of 2.49T with 3.61% growth.
Revenue (ttm)
2.52T
Revenue Growth
+4.65%
P/S Ratio
0.14
Revenue / Employee
198.38M
Employees
12,717
Market Cap
342.99B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.49T | 86.70B | 3.61% |
| Mar 31, 2025 | 2.40T | 13.46B | 0.56% |
| Mar 31, 2024 | 2.39T | 71.67B | 3.10% |
| Mar 31, 2023 | 2.31T | 82.05B | 3.67% |
| Mar 31, 2022 | 2.23T | 104.56B | 4.91% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MediPal Holdings | 3.86T |
| Alfresa Holdings | 3.13T |
| Toho Holdings | 1.58T |
| Vital KSK Holdings | 616.92B |
| Medius Holdings | 302.34B |
| OLBA HEALTHCARE HOLDINGS | 126.60B |
| AS ONE | 115.06B |
| WIN-Partners | 92.28B |
Suzuken News
- 18 days ago - Suzuken Quarterly report: Q1 2027 - Filings
- 18 days ago - Suzuken Slides: Q1 2027 - Filings
- 4 months ago - Suzuken Quarterly report: Q4 2026 - Filings
- 4 months ago - Suzuken Slides: Q4 2026 - Filings
- 6 months ago - Suzuken Slides: Q3 2026 - Filings
- 6 months ago - Suzuken Quarterly report: Q3 2026 - Filings
- 10 months ago - Suzuken Quarterly report: Q2 2026 - Filings
- 10 months ago - Suzuken Slides: Q2 2026 - Filings